Safety profile of novel amodipine salts to be elucidated, Pfizer Korea says

Amid hectic rush of Korean pharmaceutical makers to develop novel amodipine salts, Pfizer Korea expressed its concerns over their safety and efficacy, as the chemical structures of these salts are different from that of Norvasc (amlodipine besylate), the world's best-selling prescription drug in the treatment of hypertension for the past 15 years.

The company further contended that these nov...